Showing results (1-10 of 82) with videos related to

Sort By:
Pageof 9
Hamostaseologie|June 22, 2026
Diagnosis and Management of Immune Platelet Transfusion RefractorinessSara Reda, Heiko Rühl
Hamostaseologie|February 17, 2026
Management of Splanchnic Venous Thrombosis: An UpdateHeiko Rühl, Sara Reda
Hamostaseologie|July 30, 2020
Can We Measure the Individual Prothrombotic or Prohemorrhagic Tendency by Global Coagulation Tests?Sara Reda, Laure Morimont, Jonathan Douxfils, et al.
Thrombosis and Haemostasis|January 30, 2018
Activated Factor X-Based versus Thrombin-Based Antithrombin Testing in Thrombophilia Workup in the DOAC EraHeiko Rühl, Sara Reda, Jens Müller, et al.
International Journal of Laboratory Hematology|January 31, 2024
Hemostatic imbalance induced by tamoxifen in estrogen receptor-positive breast cancer patients: An observational studyMarie Didembourg, Sara Reda, Johannes Oldenburg, et al.
Scientific Reports|July 24, 2020
Functional lupus anticoagulant testing in a large retrospective cohort of thrombosis patients with direct oral anticoagulantsSara Reda, Anna Brügelmann, Jens Müller, et al.
Frontiers in Cardiovascular Medicine|October 28, 2021
PC Deficiency Testing: Thrombin-Thrombomodulin as PC Activator and Aptamer-Based Enzyme Capturing Increase Diagnostic AccuracySara Reda, Heiko Rühl, Jana Witkowski, et al.
International Journal of Molecular Sciences|March 6, 2021
Functional Characterization of Antithrombin Mutations by Monitoring of Thrombin Inhibition KineticsSara Reda, Jens Müller, Anna Pavlova, et al.
Life (Basel, Switzerland)|May 28, 2022
Variation in Plasma Levels of Apixaban and Rivaroxaban in Clinical Routine Treatment of Venous ThromboembolismSara Reda, Eva Rudde, Jens Müller, et al.
Research and Practice in Thrombosis and Haemostasis|March 15, 2024
Fibrinolysis biomarker, thrombin, and activated protein C level alterations after coagulation activation depend on type of thrombophilia and clinical phenotypeSara Reda, Nadine Schwarz, Jens Müller, et al.
Pageof 9